It was a landmark year for medical advancements in 2024, bringing a wave of innovative treatments that promise to reshape ...

Researchers from Canada reviewed the results of 26 trials to determine which of the weight loss jabs are the most effective ...

The medication ... The FDA grants orphan status to medicines and biologics for rare diseases that meet certain criteria, opening the way for incentives such as accelerated approval and tax breaks ...

Credit: Getty Images The FDA is expected to decide on treatments for Parkinson disease, PTSD and NF1-associated plexiform neurofibromas, in addition to 2 new vaccines. The FDA is reviewing the ...

Researchers at UT Southwestern Medical Center discovered that genetically modifying fat cells in obese mice to produce higher ...

As the second oral therapy approved by the U.S. Food and Drug Administration (FDA) for the treatment of Alzheimer’s disease during the past decade, ZUNVEYL demonstrates a potentially better safety ...

A pack of gummy bears may have lifted your spirits as a kid, but these days, some gummies are claiming to lift a lot more.

Discover how dopamine’s unexpected role in breaking down harmful plaques could revolutionize Alzheimer's treatment and ...

The FDA approved the oral medication July 29. 7. Voquezna (vonoprazan) for heartburn from non-erosive gastroesophageal reflux disease: Initially approved for erosive GERD, the daily oral tablet ...

stating it wants to end the “entitlement” some pharmacies have practiced in mass-marketing copies of its highly popular GLP-1 medications. The lawsuit in question concerns the FDA’s decision ...

Obese mice whose fat cells were genetically altered to produce an increased amount of the glucose-dependent insulinotropic ...

Artificial intelligence (AI) is transforming the pharmaceutical industry, revolutionising drug discovery and approval processes ... and accelerates new medications reaching the market.